Iovance Biotherapeutics
Price & Volume
Stats
See more52W Range | $6.70-$18.33 |
Market Cap | $2.2B |
Shares Short | 56M |
Financials
See moreRevenue (12 Mos) | $90.8M |
Revenue Growth (YoY) | 12,385.1% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$1.48 |
News
See moreYahoo Finance • 4 months ago
3 Monster Biotech Stocks to Buy Before 2025
Yahoo Finance • 7 months ago
Iovance Biotherapeutics Announces Clinical Data in Frontline Advanced Melanoma at ASCO 2024 Annual Meeting
Yahoo Finance • 7 months ago
Why Iovance Stock Is Down 18% Today
Yahoo Finance • 8 months ago
Got $500? These Hot Growth Stocks Are Screaming Buys Right Now
About
CEO | Dr. Frederick G. Vogt Esq., J.D., Ph.D. |
CFO | Mr. Jean-Marc Bellemin M.B.A. |
Address | 825 Industrial Road, San Carlos, CA, United States, 94070 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 557 |
